OcuCell Inc.
PrivateLast Round
Seed
Sep 26, 2023
Company Overview
OcuCell Inc. is a biotechnology company that develops regenerative cell therapies for the treatment of corneal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OcuCell Inc. Comps
Public and private peers based on sector, stage, and business model.
OcuCell Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 26, 2023 |
OcuCell Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johns Hopkins Technology Ventures | Seed |
| Eye Bank Association of America | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2023
Secured seed funding from multiple investors including Johns Hopkins Technology Ventures.
OcuCell Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OcuCell Inc.'s valuation, stock price, and market status.
